$2.87
0.3413.47%
Last update: Nov 5, 4:45 PM
OnKure Therapeutics Inc (OKUR) Stock Price, Quote, News & History
OKURNASDAQ
OnKure Therapeutics has garnered attention following its merger with Reneo Pharmaceuticals and a $65 million private placement. Oppenheimer initiated coverage...
You can purchase shares of OnKure Therapeutics (NASDAQ:OKUR) through any online brokerage.
Other companies in OnKure Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
OnKure Therapeutics has a consensus price target of $26.00.
The stock price for OnKure Therapeutics (NASDAQ: OKUR) is $2.52 last updated November 5, 2026 at 4:45 PM EST.
There are no upcoming dividends for OnKure Therapeutics.
OnKure Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for OnKure Therapeutics.
OnKure Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
OnKure Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing precision medicines that target biologically validated drivers of cancers underserved by available therapies. The company uses a...
